The	the	O	O
effect	effect	O	O
of	of	O	O
different	different	O	O
anaesthetic	anaesthetic	O	O
agents	agents	O	O
in	in	O	O
hearing	hearing	O	B_disease
loss	loss	O	I_disease
following	following	O	O
spinal	spinal	O	O
anaesthesia	anaesthesia	O	O
.	.	O	O

The	the	O	O
cause	cause	O	O
of	of	O	O
hearing	hearing	O	B_disease
loss	loss	O	I_disease
after	after	O	O
spinal	spinal	O	O
anaesthesia	anaesthesia	O	O
is	is	O	O
unknown	unknown	O	O
.	.	O	O

Up	up	O	O
until	until	O	O
now	now	O	O
,	,	O	O
the	the	O	O
only	only	O	O
factor	factor	O	O
studied	studied	O	O
has	has	O	O
been	been	O	O
the	the	O	O
effect	effect	O	O
of	of	O	O
the	the	O	O
diameter	diameter	O	O
of	of	O	O
the	the	O	O
spinal	spinal	O	O
needle	needle	O	O
on	on	O	O
post-operative	post-operative	O	O
sensorineural	sensorineural	O	B_disease
hearing	hearing	O	B_disease
loss	loss	O	I_disease
.	.	O	O

The	the	O	O
aim	aim	O	O
of	of	O	O
this	this	O	O
study	study	O	O
was	was	O	O
to	to	O	O
describe	describe	O	O
this	this	O	O
hearing	hearing	O	B_disease
loss	loss	O	I_disease
and	and	O	O
to	to	O	O
investigate	investigate	O	O
other	other	O	O
factors	factors	O	O
influencing	influencing	O	O
the	the	O	O
degree	degree	O	O
of	of	O	O
hearing	hearing	O	B_disease
loss	loss	O	I_disease
.	.	O	O

Two	two	O	O
groups	groups	O	O
of	of	O	O
22	22	O	O
similar	similar	O	O
patients	patients	O	O
were	were	O	O
studied	studied	O	O
:	:	O	O
one	one	O	O
group	group	O	O
received	received	O	O
6	6	O	O
mL	ml	O	O
prilocaine	prilocaine	S_chemical	O
2	2	O	O
%	%	O	O
;	;	O	O
and	and	O	O
the	the	O	O
other	other	O	O
received	received	O	O
3	3	O	O
mL	ml	O	O
bupivacaine	bupivacaine	S_chemical	O
0.5	0.5	O	O
%	%	O	O
.	.	O	O

Patients	patients	O	O
given	given	O	O
prilocaine	prilocaine	S_chemical	O
were	were	O	O
more	more	O	O
likely	likely	O	O
to	to	O	O
develop	develop	O	O
hearing	hearing	O	B_disease
loss	loss	O	I_disease
(	(	O	O
10	10	O	O
out	out	O	O
of	of	O	O
22	22	O	O
)	)	O	O
than	than	O	O
those	those	O	O
given	given	O	O
bupivacaine	bupivacaine	S_chemical	O
(	(	O	O
4	4	O	O
out	out	O	O
of	of	O	O
22	22	O	O
)	)	O	O
(	(	O	O
P	p	O	O
<	<	O	O
0.05	0.05	O	O
)	)	O	O
.	.	O	O

The	the	O	O
average	average	O	O
hearing	hearing	O	B_disease
loss	loss	O	I_disease
for	for	O	O
speech	speech	O	O
frequencies	frequencies	O	O
was	was	O	O
about	about	O	O
10	10	O	O
dB	db	O	O
after	after	O	O
prilocaine	prilocaine	S_chemical	O
and	and	O	O
15	15	O	O
dB	db	O	O
after	after	O	O
bupivacaine	bupivacaine	S_chemical	O
.	.	O	O

None	none	O	O
of	of	O	O
the	the	O	O
patients	patients	O	O
complained	complained	O	O
of	of	O	O
subjective	subjective	O	O
hearing	hearing	O	B_disease
loss	loss	O	I_disease
.	.	O	O

Long-term	long-term	O	O
follow-up	follow-up	O	O
of	of	O	O
the	the	O	O
patients	patients	O	O
was	was	O	O
not	not	O	O
possible	possible	O	O
.	.	O	O

